Strong Buy Biotech Stocks May 2026

Several biotechnology companies have recently earned ratings from analysts as of April 28, 2026. These ratings are often driven by positive clinical trial progress, strategic acquisitions, or analyst upgrades following strong performance. Latest Analyst "Strong Buy" Upgrades

According to TipRanks and Yahoo Finance , the following large-cap biotech stocks currently hold a consensus rating: Gilead Sciences (GILD) Regeneron Pharmaceuticals (REGN) BioNTech (BNTX) Insmed Incorporated (INSM) IQVIA Holdings (IQV) Emerging Growth & Specialized Picks strong buy biotech stocks

: Upgraded to Strong Buy by Truist Financial and BTIG Research . strong buy biotech stocks

These stocks have received specific "Strong Buy" ratings or upgrades from major financial institutions in late April 2026: strong buy biotech stocks

: Raised to Strong Buy by HC Wainwright .